CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 39 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,000 | -41.2% | 209,198 | +3.0% | 0.00% | – |
| Q2 2023 | $243,000 | -0.4% | 203,198 | -2.9% | 0.00% | -100.0% |
| Q1 2023 | $244,000 | +58.4% | 209,198 | +7.6% | 0.00% | – |
| Q4 2022 | $154,000 | -25.2% | 194,485 | +14.0% | 0.00% | -100.0% |
| Q3 2022 | $206,000 | +31.2% | 170,623 | 0.0% | 0.00% | – |
| Q2 2022 | $157,000 | -59.6% | 170,623 | -21.6% | 0.00% | -100.0% |
| Q1 2022 | $389,000 | +47.9% | 217,623 | +27.5% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | -24.2% | 170,623 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $347,000 | -41.3% | 170,623 | +0.4% | 0.00% | -50.0% |
| Q2 2021 | $591,000 | +95.0% | 169,944 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $303,000 | +74.1% | 169,944 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | – | 169,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |